To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture
Qilu Pharmaceutical Co., Ltd. · Postmenopausal Women With Osteoporosis
Phase 3
Not yet recruiting
282
2025-03